Anthony Letai, MD, PhD, FAACR, Lays Out NCI’s Priorities at the AACR Annual Meeting 2026
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
Before a new treatment becomes available for cancer patients, it must be tested in clinical trials and shown to be...
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
Expanding clinical trial eligibility requirements can help increase participation and more accurately show how treatments work in a real-world...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
This year, the American Association for Cancer Research (AACR) launched a series of Patient Advocate Forums, virtual conversations featuring...